Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore which bond type—Treasury or corporate—typically incurs lower taxes in retirement and how that shapes your income strategy.
28,027 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A move like bitcoin dips below $60,000 often sparks fear and FOMO. This guide breaks down what happened, what history...
London-listed Satsuma Technology is voting to sell its entire Bitcoin stash and delist, a decision that hinges on a J...
Detroit automakers request tariff relief from the White House as a universal levy looms, citing rising costs and supp...
The Federal Trade Commission has sent warning letters to 97 auto dealer groups, demanding that advertised car prices ...
The federal debt surpassed $39 trillion this week, marking a watershed moment for Americans’ finances and national st...
When markets tank, investors ask which asset holds up better. This article compares XRP and Shiba Inu to help you dec...
Bitcoin has clawed back from the $60,000 zone and sits near $65,000 as markets brace for the Federal Reserve’s policy...
CrowdStrike just split stock, turning a high-priced share into four easier-to-access pieces. A lower price can spark ...
Vanguard Real Estate ETF faces a crucial test as the 10-year yield that drives REIT valuations hovers near 4.6%, pote...
A Berkshire-inspired ETF touts a 15% yield by layering a stock-picker approach with an option strategy and return of ...
A focused look at a nuclear energy stock with small modular reactors (SMRs) at the center. Learn the potential upside...